Business Standard

Wall Street rallies on promising coronavirus drug; Dow, S&P rise over 2%

Big tech companies provided the biggest lift to the S&P 500 and the Nasdaq,

wall street
Premium

Drugmaker Gilead Sciences Inc announced that its drug remdesivir is showing promise as an effective Covid-19 treatment

Reuters
US stocks surged on Wednesday as hopes for an effective COVID-19 treatment prompted a broad rally and helped investors shrug off bleak GDP data and words of warning from US Federal Reserve Chair Jerome Powell.

Big tech companies provided the biggest lift to the S&P 500 and the Nasdaq, and pushed all three major US stock averages closer to their all-time highs reached in February.

All are well within 20 per cent  of their record levels, with the tech-heavy Nasdaq now within 10 per cent  of its high.Smaller companies, which stand to benefit more from restrictions being lifted on a state-by-state basis,

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 30 2020 | 3:09 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com